GELS

Gelteq Limited

$0.42

-6.12%

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Source: Yahoo Finance
Q-Score35/ 100
Market Cap$4.5M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta2.37
AI summary

Price & performance

1M-16.1%
3M-30.7%
YTD-45.3%
1Y-62.1%
52-week range—
Beta2.37
Full chart and returns against a benchmark

Q-Score

35/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk26
Performance63
Valuation28
Profitability36
Leverage33
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$108.2K+104.8%
Net income-$4.3M
Net margin—
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtNov 17, 2025
Late filing noticeNov 2, 2026
Filings, findings and the timeline

Revenue exposure

24%of revenue from outside the US
United States76%
Australia24%
Regions, segments, customers and suppliers

Valuation

GELSIndustryP/E—35.25P/S41.582.74EV/EBITDA—16.35P/B0.442.46PEG—0.87
Dividend yield0.00%
Every valuation metric